MAPT and Alzheimer disease: Therefore, there is a growing need for stronger treatments that can stop or reverse the progression of the disease; ideally, these treatments should target the complex pathophysiology of AD, which includes tau protein aggregation, oxidative stress, and neuroinflammation [9,10].